Home  »  Hot Stocks   »  ALX Oncology Holdings Inc. (ALXO) Reveals an Earni...

ALX Oncology Holdings Inc. (ALXO) Reveals an Earnings Mystery

Share on facebook
Share on twitter
Share on linkedin
Share on whatsapp

ALX Oncology Holdings Inc. (NASDAQ:ALXO) went down by -7.55% from its latest closing price compared to the recent 1-year high of $89.04. The company’s stock price has collected -5.10% of loss in the last five trading sessions. Press Release reported on 01/10/22 that ALX Oncology Provides Corporate Update and Highlights Key Milestones in 2022

Is It Worth Investing in ALX Oncology Holdings Inc. (NASDAQ :ALXO) Right Now?

Opinions of the stock are interesting as 7 analysts out of 8 who provided ratings for ALX Oncology Holdings Inc. declared the stock was a “buy,” while 0 rated the stock as “overweight,” 1 rated it as “hold,” and 0 as “sell.”

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free.


The average price from analysts is $67.75, which is $52.53 above the current price. ALXO currently public float of 25.03M and currently shorts hold a 17.61% ratio of that float. Today, the average trading volume of ALXO was 420.60K shares.

ALXO’s Market Performance

ALXO stocks went down by -5.10% for the week, with a monthly drop of -19.48% and a quarterly performance of -67.84%, while its annual performance rate touched -76.91%. The volatility ratio for the week stands at 9.48% while the volatility levels for the past 30 days are set at 8.48% for ALX Oncology Holdings Inc.. The simple moving average for the period of the last 20 days is -13.45% for ALXO stocks with a simple moving average of -65.76% for the last 200 days.

Analysts’ Opinion of ALXO

Many brokerage firms have already submitted their reports for ALXO stocks, with Jefferies repeating the rating for ALXO by listing it as a “Hold.” The predicted price for ALXO in the upcoming period, according to Jefferies is $25 based on the research report published on December 22nd of the previous year 2021.

Stifel, on the other hand, stated in their research note that they expect to see ALXO reach a price target of $106. The rating they have provided for ALXO stocks is “Buy” according to the report published on September 30th, 2021.

Credit Suisse gave a rating of “Outperform” to ALXO, setting the target price at $98 in the report published on May 05th of the previous year.

ALXO Trading at -42.18% from the 50-Day Moving Average

After a stumble in the market that brought ALXO to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -78.69% of loss for the given period.

Volatility was left at 8.48%, however, over the last 30 days, the volatility rate increased by 9.48%, as shares sank -20.96% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -67.51% lower at present.

During the last 5 trading sessions, ALXO fell by -5.10%, which changed the moving average for the period of 200-days by -72.23% in comparison to the 20-day moving average, which settled at $21.67. In addition, ALX Oncology Holdings Inc. saw -11.73% in overturn over a single year, with a tendency to cut further losses.

Insider Trading

Reports are indicating that there were more than several insider trading activities at ALXO starting from Lettmann Jason, who sale 325,377 shares at the price of $27.36 back on Dec 13. After this action, Lettmann Jason now owns 285,956 shares of ALX Oncology Holdings Inc., valued at $8,901,804 using the latest closing price.

LSV Associates, LLC, the 10% Owner of ALX Oncology Holdings Inc., sale 48,390 shares at $26.61 during a trade that took place back on Dec 13, which means that LSV Associates, LLC is holding 285,956 shares at $1,287,431 based on the most recent closing price.

Stock Fundamentals for ALXO

Current profitability levels for the company are sitting at:

  • -3693.99 for the present operating margin
  • +9.05 for the gross margin

The net margin for ALX Oncology Holdings Inc. stands at -3869.71. The total capital return value is set at -20.08, while invested capital returns managed to touch -21.03. Equity return is now at value -18.00, with -17.50 for asset returns.

>> 7 Top Picks for the Post-Pandemic Economy <<

The receivables turnover for the company is 4.41 and the total asset turnover is 0.01. The liquidity ratio also appears to be rather interesting for investors as it stands at 70.28.

Leave a Comment

Your email address will not be published. Required fields are marked *




Download Free eBook For


100% free. stop anytime no spam